Pathogenesis and diagnosis of hepatic encephalopathy

References

• Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy – definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology35(3), 716–721 (2002).
   PubMed Web of Science ®Google Scholar
• Gunnarsdottir SA, Olsson R, Olafsson S et al. Liver cirrhosis in Iceland and Sweden: incidence, aetiology and outcomes. Scand. J. Gastroenterol.44(8), 984–993 (2009).
   PubMed Web of Science ®Google Scholar
• Fleming KM, Aithal GP, Solaymani-Dodaran M, Card TR, West J. Incidence and prevalence of cirrhosis in the United Kingdom, 1992–2001: a general population-based study. J. Hepatol.49(5), 732–738 (2008).
   PubMed Web of Science ®Google Scholar
• Rikkers L, Jenko P, Rudman D, Freides D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology75(3), 462–469 (1978).
   PubMed Web of Science ®Google Scholar
• Saxena N, Bhatia M, Joshi YK, Garg PK, Tandon RK. Auditory P300 event-related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: a follow-up study. J. Gastroenterol. Hepatol.16(3), 322–327 (2001).
   PubMed Web of Science ®Google Scholar
• Bajaj JS. Minimal hepatic encephalopathy matters in daily life. World J. Gastroenterol.14(23), 3609–3615 (2008).
   PubMed Web of Science ®Google Scholar
• Bosoi CR, Rose CF. Identifying the direct effects of ammonia on the brain. Metab. Brain Dis.24(1), 95–102 (2009).
   PubMed Web of Science ®Google Scholar
• Bjerring PN, Eefsen M, Hansen BA, Larsen FS. The brain in acute liver failure. A tortuous path from hyperammonemia to cerebral edema. Metab. Brain Dis.24(1), 5–14 (2009).
   PubMed Web of Science ®Google Scholar
• Haussinger D. Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology43(6), 1187–1190 (2006).
   PubMed Web of Science ®Google Scholar
• Norenberg MD, Rao KV, Jayakumar AR. Mechanisms of ammonia-induced astrocyte swelling. Metab. Brain Dis.20(4), 303–318 (2005).
   PubMed Web of Science ®Google Scholar
• Fridman V, Galetta SL, Pruitt AA, Levine JM. MRI findings associated with acute liver failure. Neurology72(24), 2130–2131 (2009).
   PubMed Web of Science ®Google Scholar
• Berding G, Banati RB, Buchert R et al. Radiotracer imaging studies in hepatic encephalopathy: ISHEN practice guidelines. Liver Int.29(5), 621–628 (2009).
   PubMed Web of Science ®Google Scholar
• Grover VP, Dresner MA, Forton DM et al. Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy. World J. Gastroenterol.12(19), 2969–2978 (2006).
   PubMed Web of Science ®Google Scholar
• Shawcross D, Jalan R. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell. Mol. Life Sci.62(19–20), 2295–2304 (2005).
   PubMed Web of Science ®Google Scholar
• Shawcross DL, Wright G, Olde Damink SW, Jalan R. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab. Brain Dis.22(1), 125–138 (2007).
   PubMed Web of Science ®Google Scholar
• Ong JP, Aggarwal A, Krieger D et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am. J. Med.114(3), 188–193 (2003).
   PubMed Web of Science ®Google Scholar
• Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of minimal hepatic encephalopathy. Metab. Brain Dis.19(3–4), 253–267 (2004).
   PubMed Web of Science ®Google Scholar
• Iduru S, Hisamuddin K, Mullen KD. Minimal hepatic encephalopathy: simplifying its diagnosis. Am. J. Gastroenterol.102(7), 1537–1538 (2007).
   PubMed Web of Science ®Google Scholar
• Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J. Hepatol.42(Suppl. 1), S45–S53 (2005).
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am. J. Gastroenterol.102(9), 1903–1909 (2007).
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Hafeezullah M, Hoffmann RG et al. Navigation skill impairment: another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology47(2), 596–604 (2008).
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Saeian K, Hafeezullah M, Hoffmann RG, Hammeke TA. Patients with minimal hepatic encephalopathy have poor insight into their driving skills. Clin. Gastroenterol. Hepatol.6(10), 1135–1139; quiz 1065 (2008).
   PubMed Web of Science ®Google Scholar
• Kircheis G, Knoche A, Hilger N et al. Hepatic encephalopathy and fitness to drive. Gastroenterology137(5), 1706–1715 e1–e9 (2009).
   PubMed Web of Science ®Google Scholar
• Les I, Doval E, Flavia M et al. Quality of life in cirrhosis is related to potentially treatable factors. Eur. J. Gastroenterol. Hepatol.22(2), 221–227 (2009).
   Web of Science ®Google Scholar
• Bao ZJ, Qiu DK, Ma X et al. Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy. World J. Gastroenterol.13(21), 3003–3008 (2007).
   PubMed Web of Science ®Google Scholar
• Stewart CA, Smith GE. Minimal hepatic encephalopathy. Nat. Clin. Pract. Gastroenterol. Hepatol.4(12), 677–685 (2007).
   PubMedGoogle Scholar
• Bajaj JS, Etemadian A, Hafeezullah M, Saeian K. Testing for minimal hepatic encephalopathy in the United States: an AASLD survey. Hepatology45(3), 833–834 (2007).
   PubMed Web of Science ®Google Scholar
• Qadri AM, Ogunwale BO, Mullen KD. Can we ignore minimal hepatic encephalopathy any longer? Hepatology45(3), 547–548 (2007).
   PubMed Web of Science ®Google Scholar
• Shawcross D, Jalan R. Dispelling myths in the treatment of hepatic encephalopathy. Lancet365(9457), 431–433 (2005).
   PubMed Web of Science ®Google Scholar
• Nencki M, Pawlow J, Zaleski J. Uber die Bestimmung des Ammoniaks in Thierischen Fluessigkeiten und Geweben. Arch. Exp. Pathol. Pharm.36, 26–51 (1896).
   Google Scholar
• Lockwood AH, McDonald JM, Reiman RE et al. The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J. Clin. Invest.63(3), 449–460 (1979).
   PubMed Web of Science ®Google Scholar
• Lockwood AH, Yap EW, Wong WH. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J. Cereb. Blood Flow Metab.11(2), 337–341 (1991).
   PubMed Web of Science ®Google Scholar
• Dejong CH, Kampman MT, Deutz NE, Soeters PB. Cerebral cortex ammonia and glutamine metabolism during liver insufficiency-induced hyperammonemia in the rat. J. Neurochem.59(3), 1071–1079 (1992).
   PubMed Web of Science ®Google Scholar
• Rose C, Kresse W, Kettenmann H. Acute insult of ammonia leads to calcium-dependent glutamate release from cultured astrocytes, an effect of pH. J. Biol. Chem.280(22), 20937–20944 (2005).
   PubMed Web of Science ®Google Scholar
• Haussinger D, Kircheis G, Fischer R, Schliess F, vom Dahl S. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J. Hepatol.32(6), 1035–1038 (2000).
   PubMed Web of Science ®Google Scholar
• Shawcross DL, Balata S, Olde Damink SW et al. Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia. Am. J. Physiol. Gastrointest. Liver Physiol.287(3), G503–G509 (2004).
   Google Scholar
• Rose C. Effect of ammonia on astrocytic glutamate uptake/release mechanisms. J. Neurochem.1, 11–15 (2006).
   Google Scholar
• Chan H, Hazell AS, Desjardins P, Butterworth RF. Effects of ammonia on glutamate transporter (GLAST) protein and mRNA in cultured rat cortical astrocytes. Neurochem. Int.37(2–3), 243–248 (2000).
   PubMed Web of Science ®Google Scholar
• Albrecht J, Jones EA. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J. Neurol. Sci.170(2), 138–146 (1999).
   PubMed Web of Science ®Google Scholar
• Knecht K, Michalak A, Rose C, Rothstein JD, Butterworth RF. Decreased glutamate transporter (GLT-1) expression in frontal cortex of rats with acute liver failure. Neurosci. Lett.229(3), 201–203 (1997).
   PubMed Web of Science ®Google Scholar
• Norenberg MD, Huo Z, Neary JT, Roig-Cantesano A. The glial glutamate transporter in hyperammonemia and hepatic encephalopathy: relation to energy metabolism and glutamatergic neurotransmission. Glia21(1), 124–133 (1997).
   PubMed Web of Science ®Google Scholar
• Butterworth RF. Pathophysiology of hepatic encephalopathy: the concept of synergism. Hepatol. Res.38(Suppl. 1), S116–S121 (2008).
   PubMed Web of Science ®Google Scholar
• Cauli O, Mansouri MT, Agusti A, Felipo V. Hyperammonemia increases GABAergic tone in the cerebellum but decreases it in the rat cortex. Gastroenterology136(4), 1359–1367, e1351–e1352 (2009).
   PubMed Web of Science ®Google Scholar
• Cauli O, Rodrigo R, Llansola M et al. Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy. Metab. Brain Dis.24(1), 69–80 (2009).
   PubMed Web of Science ®Google Scholar
• Jones EA. Ammonia, the GABA neurotransmitter system, and hepatic encephalopathy. Metab. Brain Dis.17(4), 275–281 (2002).
   PubMed Web of Science ®Google Scholar
• Jones EA, Basile AS. Does ammonia contribute to increased GABA-ergic neurotransmission in liver failure? Metab. Brain Dis.13(4), 351–360 (1998).
   PubMed Web of Science ®Google Scholar
• Palomero-Gallagher N, Bidmon HJ, Cremer M et al. Neurotransmitter receptor imbalances in motor cortex and basal ganglia in hepatic encephalopathy. Cell. Physiol. Biochem.24(3–4), 291–306 (2009).
   PubMed Web of Science ®Google Scholar
• Norenberg MD, Rao KV, Jayakumar AR. Mechanisms of ammonia-induced astrocyte swelling. Metab. Brain Dis.20(4), 303–318 (2005).
   PubMed Web of Science ®Google Scholar
• Pittet D, Rangel-Frausto S, Li N et al. Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med.21(4), 302–309 (1995).
   PubMed Web of Science ®Google Scholar
• American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med.20(6), 864–874 (1992).
   PubMed Web of Science ®Google Scholar
• Osuchowski MF, Welch K, Siddiqui J, Remick DG. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol.177(3), 1967–1974 (2006).
   PubMed Web of Science ®Google Scholar
• Blei AT. Infection, inflammation and hepatic encephalopathy, synergism redefined. J. Hepatol.40(2), 327–330 (2004).
   PubMed Web of Science ®Google Scholar
• Fong Y, Tracey KJ, Moldawer LL et al. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1b and interleukin 6 appearance during lethal bacteremia. J. Exp. Med.170(5), 1627–1633 (1989).
   PubMed Web of Science ®Google Scholar
• Shawcross DL, Shabbir SS, Taylor NJ, Hughes RD. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology51(3), 1062–1069 (2010).
   PubMed Web of Science ®Google Scholar
• Ott P, Clemmesen O, Larsen FS. Cerebral metabolic disturbances in the brain during acute liver failure: from hyperammonemia to energy failure and proteolysis. Neurochem. Int.47(1–2), 13–18 (2005).
   PubMed Web of Science ®Google Scholar
• Didier N, Romero IA, Creminon C, Wijkhuisen A, Grassi J, Mabondzo A. Secretion of interleukin-1β by astrocytes mediates endothelin-1 and tumour necrosis factor-α effects on human brain microvascular endothelial cell permeability. J. Neurochem.86(1), 246–254 (2003).
   PubMed Web of Science ®Google Scholar
• Wichers M, Maes M. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int. J. Neuropsychopharmacol.5(4), 375–388 (2002).
   PubMed Web of Science ®Google Scholar
• Maes M, Yirmyia R, Noraberg J et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab. Brain Dis.24(1), 27–53 (2009).
   PubMed Web of Science ®Google Scholar
• Kubera M, Maes M, Kenis G, Kim YK, Lason W. Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor α and interleukin-6. Psychiatry Res.134(3), 251–258 (2005).
   PubMed Web of Science ®Google Scholar
• Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry29(2), 201–217 (2005).
   PubMed Web of Science ®Google Scholar
• Dunn AJ. Effects of cytokines and infections on brain neurochemistry. Clin. Neurosci. Res.6(1–2), 52–68 (2006).
   PubMed Web of Science ®Google Scholar
• Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J. Hepatol.40(2), 247–254 (2004).
   PubMed Web of Science ®Google Scholar
• Cagnin A, Taylor-Robinson SD, Forton DM, Banati RB. In vivo imaging of cerebral “peripheral benzodiazepine binding sites” in patients with hepatic encephalopathy. Gut55(4), 547–553 (2006).
   PubMed Web of Science ®Google Scholar
• Cagnin A, Kassiou M, Meikle SR, Banati RB. Positron emission tomography imaging of neuroinflammation. Neurotherapeutics4(3), 443–452 (2007).
   PubMed Web of Science ®Google Scholar
• Wong D, Dorovini-Zis K, Vincent SR. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood–brain barrier. Exp. Neurol.190(2), 446–455 (2004).
   PubMed Web of Science ®Google Scholar
• Montoliu C, Piedrafita B, Serra MA et al. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients. J. Mol. Med.85(3), 237–245 (2007).
   PubMed Web of Science ®Google Scholar
• Marcaida G, Felipo V, Hermenegildo C, Minana MD, Grisolia S. Acute ammonia toxicity is mediated by the NMDA type of glutamate receptors. FEBS Lett.296(1), 67–68 (1992).
   PubMed Web of Science ®Google Scholar
• Corbalan R, Chatauret N, Behrends S, Butterworth RF, Felipo V. Region selective alterations of soluble guanylate cyclase content and modulation in brain of cirrhotic patients. Hepatology36(5), 1155–1162 (2002).
   PubMed Web of Science ®Google Scholar
• Burton NC, Schneider JS, Syversen T, Guilarte TR. Effects of chronic manganese exposure on glutamatergic and GABAergic neurotransmitter markers in the nonhuman primate brain. Toxicol. Sci.111(1), 131–139 (2009).
   PubMed Web of Science ®Google Scholar
• Burton NC, Guilarte TR. Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates. Environ. Health Perspect.117(3), 325–332 (2009).
   PubMed Web of Science ®Google Scholar
• Taylor-Robinson SD, Oatridge A, Hajnal JV, Burroughs AK, McIntyre N, deSouza NM. MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metab. Brain Dis.10(2), 175–188 (1995).
   PubMed Web of Science ®Google Scholar
• Rose C, Butterworth RF, Zayed J et al. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology117(3), 640–644 (1999).
   PubMed Web of Science ®Google Scholar
• Taylor-Robinson SD, Sargentoni J, Oatridge A et al. MR imaging and spectroscopy of the basal ganglia in chronic liver disease: correlation of T1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra. Metab. Brain Dis.11(3), 249–268 (1996).
   PubMed Web of Science ®Google Scholar
• Forton DM, Patel N, Prince M et al. Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. Gut53(4), 587–592 (2004).
   PubMed Web of Science ®Google Scholar
• Jayakumar AR, Rama Rao KV, Kalaiselvi P, Norenberg MD. Combined effects of ammonia and manganese on astrocytes in culture. Neurochem. Res.29(11), 2051–2056 (2004).
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Vaidya S, Shah S, Singh J, Desai S, Bhatt M. Reversible Parkinsonism and T1W pallidal hyperintensities in acute liver failure. Mov. Disord.21(11), 1986–1990 (2006).
   PubMed Web of Science ®Google Scholar
• Fabiani G, Rogacheski E, Wiederkehr JC, Khouri J, Cianfarano A. Liver transplantation in a patient with rapid onset parkinsonism–dementia complex induced by manganism secondary to liver failure. Arq. Neuropsiquiatr.65(3A), 685–688 (2007).
   PubMed Web of Science ®Google Scholar
• Ahboucha S, Pomier-Layrargues G, Mamer O, Butterworth RF. Increased levels of pregnenolone and its neuroactive metabolite allopregnanolone in autopsied brain tissue from cirrhotic patients who died in hepatic coma. Neurochem. Int.49(4), 372–378 (2006).
   PubMed Web of Science ®Google Scholar
• Ahboucha S, Layrargues GP, Mamer O, Butterworth RF. Increased brain concentrations of a neuroinhibitory steroid in human hepatic encephalopathy. Ann Neurol.58(1), 169–170 (2005).
   PubMed Web of Science ®Google Scholar
• Belanger M, Desjardins P, Chatauret N, Rose C, Butterworth RF. Mild hypothermia prevents brain edema and attenuates up-regulation of the astrocytic benzodiazepine receptor in experimental acute liver failure. J. Hepatol.42(5), 694–699 (2005).
   PubMed Web of Science ®Google Scholar
• Ahboucha S, Butterworth RF. The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy. Metab. Brain Dis.22(3–4), 291–308 (2007).
   PubMed Web of Science ®Google Scholar
• Bender AS, Norenberg MD. Effect of benzodiazepines and neurosteroids on ammonia-induced swelling in cultured astrocytes. J. Neurosci. Res.54(5), 673–680 (1998).
   PubMed Web of Science ®Google Scholar
• Venturini I, Corsi L, Avallone R et al. Ammonia and endogenous benzodiazepine-like compounds in the pathogenesis of hepatic encephalopathy. Scand. J. Gastroenterol.36(4), 423–425 (2001).
   PubMed Web of Science ®Google Scholar
• Ahboucha S, Pomier-Layrargues G, Butterworth RF. Increased brain concentrations of endogenous (non-benzodiazepine) GABA-A receptor ligands in human hepatic encephalopathy. Metab. Brain Dis.19(3–4), 241–251 (2004).
   PubMed Web of Science ®Google Scholar
• Baraldi M, Avallone R, Corsi L, Venturini I, Baraldi C, Zeneroli ML. Natural endogenous ligands for benzodiazepine receptors in hepatic encephalopathy. Metab. Brain Dis.24(1), 81–93 (2009).
   PubMed Web of Science ®Google Scholar
• Haussinger D, Gorg B, Reinehr R, Schliess F. Protein tyrosine nitration in hyperammonemia and hepatic encephalopathy. Metab. Brain Dis.20(4), 285–294 (2005).
   PubMed Web of Science ®Google Scholar
• Albrecht J, Norenberg MD. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology44(4), 788–794 (2006).
   PubMed Web of Science ®Google Scholar
• Reinehr R, Gorg B, Becker S et al. Hypoosmotic swelling and ammonia increase oxidative stress by NADPH oxidase in cultured astrocytes and vital brain slices. Glia55(7), 758–771 (2007).
   PubMed Web of Science ®Google Scholar
• Alvarez-Leefmans FJ, Herrera-Perez JJ, Marquez MS, Blanco VM. Simultaneous measurement of water volume and pH in single cells using BCECF and fluorescence imaging microscopy. Biophys. J.90(2), 608–618 (2006).
   PubMed Web of Science ®Google Scholar
• Jayakumar AR, Rao KV, Murthy ChR, Norenberg MD. Glutamine in the mechanism of ammonia-induced astrocyte swelling. Neurochem. Int.48(6–7), 623–628 (2006).
   PubMed Web of Science ®Google Scholar
• Wendon JA, Harrison PM, Keays R, Williams R. Cerebral blood flow and metabolism in fulminant liver failure. Hepatology19(6), 1407–1413 (1994).
   PubMed Web of Science ®Google Scholar
• Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N. Engl. J. Med.324(26), 1852–1857 (1991).
   PubMed Web of Science ®Google Scholar
• Haussinger D, Schliess F. Astrocyte swelling and protein tyrosine nitration in hepatic encephalopathy. Neurochem. Int.47(1–2), 64–70 (2005).
   PubMed Web of Science ®Google Scholar
• Haussinger D, Schliess F, Kircheis G. Pathogenesis of hepatic encephalopathy. J. Gastroenterol. Hepatol.17(Suppl. 3), S256–S259 (2002).
   PubMedGoogle Scholar
• Shah NJ, Neeb H, Kircheis G, Engels P, Haussinger D, Zilles K. Quantitative cerebral water content mapping in hepatic encephalopathy. Neuroimage41(3), 706–717 (2008).
   PubMed Web of Science ®Google Scholar
• Cordoba J, Alonso J, Rovira A et al. The development of low-grade cerebral edema in cirrhosis is supported by the evolution of 1H-magnetic resonance abnormalities after liver transplantation. J. Hepatol.35(5), 598–604 (2001).
   PubMed Web of Science ®Google Scholar
• Trey C, Davidson CS. The management of fulminant hepatic failure. Prog. Liver Dis.3, 282–298 (1970).
   PubMedGoogle Scholar
• O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet342(8866), 273–275 (1993).
   PubMed Web of Science ®Google Scholar
• O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology97(2), 439–445 (1989).
   PubMed Web of Science ®Google Scholar
• Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology29(3), 648–653 (1999).
   PubMed Web of Science ®Google Scholar
• Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med. Image Anal.5(2), 143–156 (2001).
   PubMed Web of Science ®Google Scholar
• Smith SM, De Stefano N, Jenkinson M, Matthews PM. Normalized accurate measurement of longitudinal brain change. J. Comput. Assist. Tomogr.25(3), 466–475 (2001).
   PubMed Web of Science ®Google Scholar
• Patel N, White S, Dhanjal NS, Oatridge A, Taylor-Robinson SD. Changes in brain size in hepatic encephalopathy: a coregistered MRI study. Metab. Brain Dis.19(3–4), 431–445 (2004).
   PubMed Web of Science ®Google Scholar
• Babington JR, Stahl JH, Coy DL. Reversible cytotoxic edema in a cirrhotic patient following TIPS. J. Neuroimaging19(4), 391–393 (2009).
   PubMed Web of Science ®Google Scholar
• Saraswat VA, Saksena S, Nath K et al. Evaluation of mannitol effect in patients with acute hepatic failure and acute-on-chronic liver failure using conventional MRI, diffusion tensor imaging and in vivo proton MR spectroscopy. World J. Gastroenterol.14(26), 4168–4178 (2008).
   PubMed Web of Science ®Google Scholar
• Rai V, Nath K, Saraswat VA, Purwar A, Rathore RK, Gupta RK. Measurement of cytotoxic and interstitial components of cerebral edema in acute hepatic failure by diffusion tensor imaging. J. Magn. Reson. Imaging28(2), 334–341 (2008).
   PubMed Web of Science ®Google Scholar
• Lodi R, Tonon C, Stracciari A et al. Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics. Neurology62(5), 762–766 (2004).
   PubMed Web of Science ®Google Scholar
• Sugimoto R, Iwasa M, Maeda M et al. Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy. Am. J. Gastroenterol.103(6), 1413–1420 (2008).
   PubMed Web of Science ®Google Scholar
• Rovira A, Grive E, Pedraza S, Alonso J. Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis. AJNR Am. J. Neuroradiol.22(6), 1137–1142 (2001).
   PubMed Web of Science ®Google Scholar
• Minguez B, Garcia-Pagan JC, Bosch J et al. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. Hepatology43(4), 707–714 (2006).
   PubMed Web of Science ®Google Scholar
• Miese F, Kircheis G, Wittsack HJ et al.1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. AJNR Am. J. Neuroradiol.27(5), 1019–1026 (2006).
   PubMed Web of Science ®Google Scholar
• Miese FR, Wittsack HJ, Kircheis G et al. Voxel-based analyses of magnetization transfer imaging of the brain in hepatic encephalopathy. World J. Gastroenterol.15(41), 5157–5164 (2009).
   PubMed Web of Science ®Google Scholar
• Singhal A, Nagarajan R, Kumar R, Huda A, Gupta RK, Thomas MA. Magnetic resonance T2-relaxometry and 2D L-correlated spectroscopy in patients with minimal hepatic encephalopathy. J. Magn. Reson. Imaging30(5), 1034–1041 (2009).
   PubMed Web of Science ®Google Scholar
• Neuberger J, Gimson A, Davies M et al. Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut57(2), 252–257 (2008).
   PubMed Web of Science ®Google Scholar
• Atterbury CE, Maddrey WC, Conn HO. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am. J. Dig. Dis.23(5), 398–406 (1978).
   PubMedGoogle Scholar
• Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet2(7872), 81–84 (1974).
   PubMed Web of Science ®Google Scholar
• Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology46(6), 1844–1852 (2007).
   PubMed Web of Science ®Google Scholar
• Kitzberger R, Funk GC, Holzinger U et al. Severity of organ failure is an independent predictor of intracranial hypertension in acute liver failure. Clin. Gastroenterol. Hepatol.7(9), 1000–1006 (2009).
   PubMed Web of Science ®Google Scholar
• Krieger S, Jauss M, Jansen O, Theilmann L, Geissler M, Krieger D. Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology111(1), 147–155 (1996).
   PubMed Web of Science ®Google Scholar
• Mullen KD, Cole M, Foley JM. Neurological deficits in “awake” cirrhotic patients on hepatic encephalopathy treatment: missed metabolic or metal disorder? Gastroenterology111(1), 256–257 (1996).
   PubMed Web of Science ®Google Scholar
• Kundra A, Jain A, Banga A, Bajaj G, Kar P. Evaluation of plasma ammonia levels in patients with acute liver failure and chronic liver disease and its correlation with the severity of hepatic encephalopathy and clinical features of raised intracranial tension. Clin. Biochem.38(8), 696–699 (2005).
   PubMed Web of Science ®Google Scholar
• Kramer L, Tribl B, Gendo A et al. Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology31(1), 30–34 (2000).
   PubMed Web of Science ®Google Scholar
• Albrecht J. Cyclic GMP in blood and minimal hepatic encephalopathy: fine-tuning of the diagnosis. J. Mol. Med.85(3), 203–205 (2007).
   PubMed Web of Science ®Google Scholar
• Montoliu C, Rodrigo R, Monfort P et al. Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications. Metab. Brain Dis.25(1), 37–48 (2010).
   Google Scholar
• Montoliu C, Piedrafita B, Serra MA et al. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J. Clin. Gastroenterol.43(3), 272–279 (2009).
   PubMed Web of Science ®Google Scholar
• Foley JM, Watson CW, Adams RD. Significance of the electroencephalographic changes in hepatic coma. Trans. Am. Neurol. Assoc.51, 161–165 (1950).
   PubMedGoogle Scholar
• Bickford RG, Butt HR. Hepatic coma: the electroencephalographic pattern. J. Clin. Invest.34(6), 790–799 (1955).
   PubMed Web of Science ®Google Scholar
• Fisch BJ, Klass DW. The diagnostic specificity of triphasic wave patterns. Electroencephalogr. Clin. Neurophysiol.70(1), 1–8 (1988).
   PubMedGoogle Scholar
• Amodio P, Orsato R, Marchetti P et al. Electroencephalographic analysis for the assessment of hepatic encephalopathy: comparison of non-parametric and parametric spectral estimation techniques. Neurophysiol. Clin.39(2), 107–115 (2009).
   PubMed Web of Science ®Google Scholar
• Montagnese S, Jackson C, Morgan MY. Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis. J. Hepatol.46(3), 447–458 (2007).
   PubMed Web of Science ®Google Scholar
• Kullmann F, Hollerbach S, Lock G, Holstege A, Dierks T, Scholmerich J. Brain electrical activity mapping of EEG for the diagnosis of (sub)clinical hepatic encephalopathy in chronic liver disease. Eur. J. Gastroenterol. Hepatol.13(5), 513–522 (2001).
   PubMed Web of Science ®Google Scholar
• Guerit JM, Amantini A, Fischer C et al. Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines. Liver Int.29(6), 789–796 (2009).
   PubMed Web of Science ®Google Scholar
• Kugler CF, Lotterer E, Petter J et al. Visual event-related P300 potentials in early portosystemic encephalopathy. Gastroenterology103(1), 302–310 (1992).
   PubMed Web of Science ®Google Scholar
• Yang SS, Wu CH, Chiang TR, Chen DS. Somatosensory evoked potentials in subclinical portosystemic encephalopathy: a comparison with psychometric tests. Hepatology27(2), 357–361 (1998).
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Hafeezullah M, Franco J et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology135(5), 1591–1600.e1 (2008).
   PubMed Web of Science ®Google Scholar
• Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology35(2), 357–366 (2002).
   PubMed Web of Science ®Google Scholar
• Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J. Hepatol.47(1), 67–73 (2007).
   PubMed Web of Science ®Google Scholar
• Romero-Gomez M, Cordoba J, Jover R et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology45(4), 879–885 (2007).
   PubMed Web of Science ®Google Scholar
• Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J. Hepatol.34(5), 768–773 (2001).
   PubMed Web of Science ®Google Scholar
• Mooney S, Hasssanein TI, Hilsabeck RC et al. Utility of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in patients with end-stage liver disease awaiting liver transplant. Arch. Clin. Neuropsychol.22(2), 175–186 (2007).
   PubMed Web of Science ®Google Scholar
• Sorrell JH, Zolnikov BJ, Sharma A, Jinnai I. Cognitive impairment in people diagnosed with end-stage liver disease evaluated for liver transplantation. Psychiatry Clin. Neurosci.60(2), 174–181 (2006).
   PubMed Web of Science ®Google Scholar
• Randolph C, Hilsabeck R, Kato A et al. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int.29(5), 629–635 (2009).
   PubMed Web of Science ®Google Scholar
• Mardini H, Saxby BK, Record CO. Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant. Gastroenterology135(5), 1582–1590 (2008).
   PubMed Web of Science ®Google Scholar
• Zeneroli ML, Cioni G, Crisi G, Vezzelli C, Ventura E. Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: an MR imaging study. Magn. Reson. Imaging9(3), 295–302 (1991).
   PubMed Web of Science ®Google Scholar
• Pujol A, Graus F, Peri J, Mercader JM, Rimola A. Hyperintensity in the globus pallidus on T1-weighted and inversion-recovery MRI: a possible marker of advanced liver disease. Neurology41(9), 1526–1527 (1991).
   PubMed Web of Science ®Google Scholar
• Uchino A, Hasuo K, Matsumoto S, Masuda K. Cerebral magnetic resonance imaging of liver cirrhosis patients. Clin. Imaging18(2), 123–130 (1994).
   PubMed Web of Science ®Google Scholar
• Layrargues GP, Shapcott D, Spahr L, Butterworth RF. Accumulation of manganese and copper in pallidum of cirrhotic patients: role in the pathogenesis of hepatic encephalopathy? Metab. Brain Dis.10(4), 353–356 (1995).
   PubMed Web of Science ®Google Scholar
• Binesh N, Huda A, Thomas MA et al. Hepatic encephalopathy: a neurochemical, neuroanatomical, and neuropsychological study. J. Appl. Clin. Med. Phys.7(1), 86–96 (2006).
   PubMed Web of Science ®Google Scholar
• Mizuta Y, Ijyuin H, Ono N et al. [Disappearance of basal ganglia hyperintensity on T1-weighted MR images after obliterating portal systemic shunt in a patient with hepatic encephalopathy]. Nippon Shokakibyo Gakkai Zasshi99(12), 1487–1492 (2002).
   PubMedGoogle Scholar
• Fukuzawa T, Matsutani S, Maruyama H, Akiike T, Saisho H, Hattori T. Magnetic resonance images of the globus pallidus in patients with idiopathic portal hypertension: a quantitative analysis of the relationship between signal intensity and the grade of portosystemic shunt. J. Gastroenterol. Hepatol.21(5), 902–907 (2006).
   PubMed Web of Science ®Google Scholar
• Das K, Singh P, Chawla Y, Duseja A, Dhiman RK, Suri S. Magnetic resonance imaging of brain in patients with cirrhotic and non-cirrhotic portal hypertension. Dig. Dis. Sci.53(10), 2793–2798 (2008).
   PubMed Web of Science ®Google Scholar
• Weissenborn K, Ehrenheim C, Hori A, Kubicka S, Manns MP. Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation. Metab. Brain Dis.10(3), 219–231 (1995).
   PubMed Web of Science ®Google Scholar
• Nolte W, Wiltfang J, Schindler CG et al. Bright basal ganglia in T1-weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy. J. Hepatol.29(3), 443–449 (1998).
   PubMed Web of Science ®Google Scholar
• Cordoba J, Olive G, Alonso J et al. Improvement of magnetic resonance spectroscopic abnormalities but not pallidal hyperintensity followed amelioration of hepatic encephalopathy after occlusion of a large spleno-renal shunt. J. Hepatol.34(1), 176–178 (2001).
   PubMed Web of Science ®Google Scholar
• Taylor-Robinson SD, Sargentoni J, Marcus CD, Morgan MY, Bryant DJ. Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab. Brain Dis.9(4), 347–359 (1994).
   PubMed Web of Science ®Google Scholar
• Haussinger D, Laubenberger J, vom Dahl S et al. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology107(5), 1475–1480 (1994).
   PubMed Web of Science ®Google Scholar
• Taylor-Robinson SD, Sargentoni J, Mallalieu RJ et al. Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy. Hepatology20(5), 1173–1178 (1994).
   PubMed Web of Science ®Google Scholar
• Taylor-Robinson SD, Buckley C, Changani KK, Hodgson HJ, Bell JD. Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy. Liver19(5), 389–398 (1999).
   PubMedGoogle Scholar
• Mas VR, Fisher RA, Archer KJ, Maluf DG. Proteomics and liver fibrosis: identifying markers of fibrogenesis. Expert Rev. Proteomics6(4), 421–431 (2009).
   PubMed Web of Science ®Google Scholar
• Williams HR, Cox IJ, Taylor-Robinson SD. Metabonomics in hepatic encephalopathy: lucidity emerging from confusion. Liver Int.28(8), 1050–1051 (2008).
   PubMed Web of Science ®Google Scholar
• James P. Protein identification in the post-genome era: the rapid rise of proteomics. Q. Rev. Biophys.30(4), 279–331 (1997).
   PubMed Web of Science ®Google Scholar
• Goodacre R. Metabolomics shows the way to new discoveries. Genome Biol.6(11), 354 (2005).
   PubMedGoogle Scholar
• Weckwerth W, Morgenthal K. Metabolomics: from pattern recognition to biological interpretation. Drug Discov. Today10(22), 1551–1558 (2005).
   PubMed Web of Science ®Google Scholar
• Bajaj JS. Management options for minimal hepatic encephalopathy. Expert Rev. Gastroenterol. Hepatol.2(6), 785–790 (2008).
   PubMedGoogle Scholar
• Barba I, Chatauret N, Garcia-Dorado D, Cordoba J. A 1H nuclear magnetic resonance-based metabonomic approach for grading hepatic encephalopathy and monitoring the effects of therapeutic hypothermia in rats. Liver Int.28(8), 1141–1148 (2008).
   PubMed Web of Science ®Google Scholar
• Conn HO, Bircher J (Eds). Hepatic Encephalopathy: Syndromes and Therapies. Medi-Ed Press, MI, USA (1994).
   Google Scholar